Search Within

Sloan Kettering Institute Postdocs

Formats
  1. Journal Article (8036)
  2. Meeting Abstract (3693)
  3. Review (630)
  4. Editorial (262)
  5. Book Section (195)
  6. Conference Paper (161)
  7. Research Letter (139)
  8. Correspondence (68)
  9. Miscellaneous (67)
  10. Guidelines (30)
  11. Book Whole (6)
Groups
  1. GSK Faculty (6363)
  2. Department of Medicine (4809)
  3. Sloan Kettering Institute Faculty (3570)
  4. Center for Molecular Imaging and Biotechnology (CMIB) (3037)
  5. Surgery (2633)
  6. Solid Tumor Oncology Division (2604)

More Groups

People
  1. Britta Weigelt (376)
  2. Jorge Reis-Filho (328)
  3. Mithat Gonen (318)
  4. Marc Ladanyi (309)
  5. Michael Berger (288)
  6. Joseph Deasy (285)

More People

Years
  1. 2026 (1)
  2. 2025 (697)
  3. 2024 (1080)
  4. 2023 (1152)
  5. 2022 (1366)
  6. 2021 (1179)

More Years

Publications
  1. Blood (680)
  2. Cancer Research (543)
  3. Journal of Clinical Oncology (431)
  4. Journal of Nuclear Medicine (271)
  5. Annals of Surgical Oncology (264)
  6. Clinical Cancer Research (249)

More Publications

Publishers
  1. Nature Publishing Group (1349)
  2. Elsevier Inc. (1106)
  3. American Association for Cancer Research (1058)
  4. Springer (840)
  5. American Society of Hematology (740)
  6. Cell Press (740)

More Publishers

Results (13287)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Differences between screen-detected and interval breast cancers among BRCA mutation carriers
    Meeting Abstract

    Pilewskie, M. L.; Zabor, E. C.; Stempel, M.; Petruolo, O.; Mangino, D.; Robson, M. E.; Jochelson, M. S.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Tumor mutation burden and efficacy of targeted therapy in patients with EGFR mutant lung cancers
    Meeting Abstract

    Offin, M. D.; Rizvi, H.; Tenet, M.; Ni, A.; Sanchez Vega, F.; Kris, M. G.; Rudin, C. M.; Riely, G. J.; Yu, H. A.; Hellmann, M. D.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Transcriptional and post-transcriptional regulation of ribonucleotide reductase (RRM2) control its oncogenic role in prostate cancer progression
    Meeting Abstract

    Mazzu, Y. Z.; Armenia, J.; Chakraborty, G.; Yoshikawa, Y.; Gerke, T. A.; Atiq, M. O.; Stopsack, K. H.; Komura, K.; Lee, G. S. M.; Mucci, L. A.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Radiotherapy to demonstrate persistent overall survival benefit in locally advanced or metastatic anaplastic thyroid cancer
    Meeting Abstract

    Ma, J.; Bell, A. C.; Lok, B. H.; Leeman, J. E.; Anderson, E. S.; Riaz, N.; McBride, S. M.; Ganly, I.; Shaha, A. R.; Sherman, E. J.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Detection of germline homologous recombination deficiency (HRD) in patients with metastatic esophagogastric (EG) cancer using clinical next generation sequencing (NGS)
    Meeting Abstract

    Janjigian, Y. Y.; Jonsson, P.; Kemel, Y.; Joseph, V.; Tuvy, Y.; Shameer, Z.; Ravichandran, V.; Zhang, L. Y.; Mandelker, D.; Ku, G. Y.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Molecular underpinnings of clinical disparity patterns in African American (AA) versus Caucasian American (CA) multiple myeloma (MM) patients
    Meeting Abstract

    Hill, E. M.; Kwok, M.; Yellapantula, V.; Hultcrantz, M.; Korde, N.; Mailankody, S.; Papaemmanuil, E.; Maric, I.; Kazandjian, D. G.; Landgren, O.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Multigene sequencing, copy number alteration detection, and survival with first-line PD-1 based therapy in patients with mucosal melanoma
    Meeting Abstract

    Gottesdiener, L. S.; Gormally, M.; Armenia, J.; El-Jalby, M.; Postow, M. A.; Callahan, M. K.; Momtaz, P.; Wolchok, J. D.; Chapman, P. B.; Schultz, N.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • A bi-institutional phase II study of hepatic arterial infusion (HAI) with floxuridine (FUDR) and dexamethasone (Dex) combined with systemic gemcitabine and oxaliplatin (GemOx) for unresectable intrahepatic cholangiocarcinoma (ICC)
    Meeting Abstract

    Cercek, A.; Kemeny, N. E.; Boerner, T.; Tan, B. R.; Chou, J. F.; Gonen, M.; Boucher, T. M.; Hauser, H.; Do, R. K. G.; Lowery, M. A.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • BRCA2-RB1 co-loss and ADT resistance in aggressive prostate cancer
    Meeting Abstract

    Chakraborty, G.; Armenia, J.; Mazzu, Y. Z.; Stopsack, K. H.; Atiq, M. O.; Chadalavada, K.; Nanjangud, G.; Khan, N.; Komura, K.; Yoshikawa, Y.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Peptide receptor radionuclide therapy (PRRT) transcriptomic signature in blood for prediction of (177)Lu-octreotate efficacy
    Meeting Abstract

    Bodei, L.; Kidd, M. S.; Singh, A.; van der Zwan, W. A.; Severi, S.; Drozdov, I.; Cwikla, J. B.; Baum, R. P.; Kwekkeboom, D. J.; Paganelli, G.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save